Literature DB >> 2930927

Whole bladder photodynamic therapy for transitional cell carcinoma of bladder.

U O Nseyo, T J Dougherty, D G Boyle, W R Potter, R Wolf, R Huben, J E Pontes.   

Abstract

Our preliminary studies indicate that the bulb-tip technique for whole bladder photodynamic therapy (PDT) illuminates the entire bladder mucosa and is applicable to the management of superficial transitional cell carcinoma of the bladder. This treatment modality may be an option to patients who are failures to other standard treatments. A randomized clinical study is needed to decide on PDT as a primary treatment of choice for transitional cell carcinoma of the bladder.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2930927     DOI： 10.1016/0090-4295(85)90125-6

Source DB:  PubMed          Journal:  Urology        ISSN： 0090-4295            Impact factor:   2.649


  8 in total

1.  Anti-angiogenic activity of selected receptor tyrosine kinase inhibitors, PD166285 and PD173074: implications for combination treatment with photodynamic therapy.

Authors:  C J Dimitroff; W Klohs; A Sharma; P Pera; D Driscoll; J Veith; R Steinkampf; M Schroeder; S Klutchko; A Sumlin; B Henderson; T J Dougherty; R J Bernacki
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.850

2.  The Nd:YAG laser and methylene blue staining in the diagnosis and treatment of premalignant vesical lesions and carcinoma in situ (CIS).

Authors:  F Gaboardi; R Bordinazzo; L Galli
Journal:  Int Urol Nephrol       Date:  1989       Impact factor: 2.370

3.  The photodynamic effect of a pulsed dye laser on human bladder carcinoma cells in vitro.

Authors:  A J Pope; J R Masters; A J MacRobert
Journal:  Urol Res       Date:  1990

4.  Multi-OMIC profiling of survival and metabolic signaling networks in cells subjected to photodynamic therapy.

Authors:  Ruud Weijer; Séverine Clavier; Esther A Zaal; Maud M E Pijls; Robert T van Kooten; Klaas Vermaas; René Leen; Aldo Jongejan; Perry D Moerland; Antoine H C van Kampen; André B P van Kuilenburg; Celia R Berkers; Simone Lemeer; Michal Heger
Journal:  Cell Mol Life Sci       Date:  2016-11-01       Impact factor: 9.261

Review 5.  Current Clinical Trials in Non-muscle-Invasive Bladder Cancer: Heightened Need in an Era of Chronic BCG Shortage.

Authors:  Vignesh T Packiam; Ryan P Werntz; Gary D Steinberg
Journal:  Curr Urol Rep       Date:  2019-11-28       Impact factor: 2.862

6.  Functional and histological damage in the mouse bladder after photodynamic therapy.

Authors:  F A Stewart; Y Oussoren; J A te Poele; S Horenblas; W J Mooi
Journal:  Br J Cancer       Date:  1992-06       Impact factor: 7.640

7.  Quantitative studies of the kinetics of 5-aminolaevulinic acid-induced fluorescence in bladder transitional cell carcinoma.

Authors:  S N Datta; C S Loh; A J MacRobert; S D Whatley; P N Matthews
Journal:  Br J Cancer       Date:  1998-10       Impact factor: 7.640

8.  The effect of localized porphyrin photodynamic therapy on the induction of tumour metastasis.

Authors:  C J Gomer; A Ferrario; A L Murphree
Journal:  Br J Cancer       Date:  1987-07       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.